New Strategy for COVID-19: An Evolutionary Role for RGD Motif in SARS-CoV-2 and Potential Inhibitors for Virus Infection
Shijia Yan, Haixia Sun, Xianzhang Bu, Guohui Wan
Abstract
OPINION article Front. Pharmacol., 12 June 2020Sec. Experimental Pharmacology and Drug Discovery Volume 11 - 2020 | https://doi.org/10.3389/fphar.2020.00912
Topics & Concepts
Coronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakVirologyVirusSars virusDrug repositioningMedicineDrug discoveryPandemicComputational biologyDrugBiologyBioinformaticsPharmacologyInfectious disease (medical specialty)Internal medicineOutbreakDiseaseSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesComputational Drug Discovery Methods